Thermo Fisher Scientific (TMO) Cash & Current Investments (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Cash & Current Investments for 18 consecutive years, with $3.3 billion the latest figure, recorded in Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $3.3 billion, down 45.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.3 billion (down 45.25% YoY), and the FY2025 annual result was $10.1 billion, up 81.42% from the prior year.
• Cash & Current Investments was $3.3 billion for Q1 2026 at Thermo Fisher Scientific, down from $10.1 billion in the prior quarter.
• Over five years, Cash & Current Investments peaked at $10.1 billion in Q4 2025 and troughed at $1.9 billion in Q3 2022.
• Average Cash & Current Investments over 5 years is $5.6 billion, with a median of $5.9 billion recorded in 2025.
• Year-over-year, Cash & Current Investments slumped 75.73% in 2022 and surged 181.62% in 2024.
• Over 5 years, Cash & Current Investments stood at $8.5 billion in 2022, then decreased by 5.21% to $8.1 billion in 2023, then sank by 31.06% to $5.6 billion in 2024, then surged by 81.42% to $10.1 billion in 2025, then sank by 67.78% to $3.3 billion in 2026.
• Per Business Quant data, the three most recent Cash & Current Investments figures were $3.3 billion in Q1 2026, $10.1 billion in Q4 2025, and $3.5 billion in Q3 2025.